Category: Forbes

This AI Startup Wants To Be The Next Nvidia By Building Brain Cell-Powered Computers

At Cortical Labs, CEO Hon Weng Chong is building biological computers that he hopes will not just surpass AI, but supercharge growth of other companies.

Hot, Sunny Days With Poor Air Quality Might Make Dogs Aggressive

According to a recent Scientific Reports study, dog bites might take place around 11% more frequently than usual on hot and sunny days with high air pollution levels.

RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage Trial

GSK said its shot, the world’s first authorized RSV vaccine, showed protection in older adults for two seasons after a single dose.

Healthcare Costs Will Increase Significantly Over The Next Decade

There is a crisis ahead, and leaders must act now.

China Stocks Routed Amid Growth Worries; Alibaba Drops 4.5% After Surprise Leadership Switch

Billions of dollars of market capitalization in China shares wiped out

Vanderbilt Hospital Turns Over Transgender Clinic Records To GOP Attorney General In Investigation

Vanderbilt University Medical Center, which operated the Pediatric Transgender Transgender Clinic until a new state law forced it to shutter, handed over transgender patient records as part of a medical billing fraud investigation.

Judge Strikes Down Arkansas’ Gender-Affirming Care Ban

An Arkansas law banning gender-affirming care for transgender minors was blocked by a U.S. district judge who called the policy unconstitutional.

‘Common Ground’: Tribeca Film Connects Regenerative Farming, Politics And Public Health

In new documentary, Laura Dern joins star-studded cast to explore regenerative farming, climate change, cancer and other illnesses

‘Common Ground’: Tribeca Film Connects Regenerative Farming, Politics And Public Health

In new documentary, Laura Dern joins star-studded cast to explore regenerative farming, climate change, cancer and other illnesses

Cancer Treatment CAR T Therapy Prolongs Survival Over Standard Care

Newly released study results demonstrate that Yescarta, a CAR T therapy, prolongs survival longer than standard care for patients with early relapsed or refractory DLBCL